Innate Immunotherapeutics Limited (IIL) is a medical biotechnology company with offices in Sydney and Auckland. The Company has designed and manufactured a unique immunomodulator microparticle technology that can be used to induce the human immune system to fight certain cancers and infections, or modulate certain immune mechanisms implicated in autoimmune diseases such as Multiple Sclerosis.